First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
19 hedge funds and large institutions have $7.04M invested in First Trust Nasdaq Pharmaceuticals ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$230K | |
| 2 | +$142K | |
| 3 | +$43.4K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$28.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$23.2K |
Top Sellers
| 1 | -$144K | |
| 2 | -$57K | |
| 3 | -$48.9K | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
-$47.1K |
| 5 |
Goldman Sachs
New York
|
-$13.8K |
